AstraZeneca Q2 profits up 22 pct
AstraZeneca Q2 profits up 22 pct
AstraZeneca PLC posted a 22 percent rise in second quarter net profit on Thursday as it also revealed that a key new drug — its blood thinner Brilinta — has been given a thumbs up by an advisory committee of the U.S. Food and Drug Administration.
Read more on AP via Yahoo! News
Related posts:
- AstraZeneca shares jump in London after US court victory to protect cholesterol drug patent AstraZeneca shares jump in London after US court victory to...
- Merck settles patent dispute on cholesterol drug Merck settles patent dispute on cholesterol drug Merck & Co....
- Warning over cholesterol drug side effects Warning over cholesterol drug side effects Cholesterol-lowering drugs taken by...
- Five heart-smart snacks that knock out cholesterol Five heart-smart snacks that knock out cholesterol Reducing cholesterol intake...
- Laughter Affects Body Like Exercise Laughter Affects Body Like Exercise Quite possibly. While toning thighs...
Related posts brought to you by Yet Another Related Posts Plugin.
Filed Under Cholesterol Chart | Leave a Comment
Tagged With AstraZeneca, profits
Comments
Leave a Reply